Compounding: FDA Refining Post-Inspection Hand-off To States
Executive Summary
When the agency finds a traditional compounder during an inspection, it asks state boards of pharmacy to ensure corrections are made.
You may also be interested in...
FDA Compounding Definition Brings States Into Oversight Fold
State regulators seem to agree with FDA about confusion over regulatory responsibility, saying writing consistent definitions for compounding and manufacturing will help determine future FDA involvement.
Compounding The Problem: Congress, FDA Argue Over Regulatory Responsibility
After the House and Senate question whether FDA needs more authority to regulate compounders like the New England Compounding Center, Sen. Lamar Alexander suggests clearly designating who has jurisdiction may be the answer.
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.